Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 26 August 2008
Vol. 1, Issue 34, p. pt5
[DOI: 10.1126/scisignal.134pt5]

PRESENTATIONS

Defining Drug Targets in Yeast Haploinsufficiency Screens: Application to Human Translational Pharmacology

Michel Roberge*

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

A presentation from the American Society for Pharmacology and Experimental Therapeutics (ASPET) Centennial Meeting at the Experimental Biology 2008 Meeting, San Diego, California, 5 to 9 April 2008.

Abstract: A major challenge in drug discovery is to identify the cellular targets responsible for the pharmacological activity of drug candidates. In the yeast Saccharomyces cerevisiae, a heterozygous diploid mutant collection of ~6000 strains, in each of which one copy of a single gene is deleted, is commercially available. With this collection, it is possible to evaluate the role of each gene product in the response of cells to a drug. Drug-induced haploinsufficiency refers to the situation where a heterozygous diploid mutant is more sensitive to a drug than is the wild-type strain. Drug-induced haploinsufficiency screening has the potential to reveal pharmacological targets of drugs and those that contribute to undesired side effects, as well as gene products involved in drug transport, metabolism, or resistance. Using published studies, I present advantages and limitations of this technique and discuss its value for predicting drug targets in human cells.

*Presenter and corresponding author. E-mail, michelr{at}interchange.ubc.ca

Citation: M. Roberge, Defining Drug Targets in Yeast Haploinsufficiency Screens: Application to Human Translational Pharmacology. Sci. Signal. 1, pt5 (2008).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882